OIP — The Opportunity Intelligence PlatformMy OIPOIP / Government Intelligence
Preparing the stored Government Intelligence discovery view.
OIP / Government Intelligence / Opportunity detail
Source: Stored live-derived Government dataNational Institutes of Health
OIP derived this review page from stored live-derived Government Intelligence source records. The official source and issuing agency remain authoritative.
Opportunity Intelligence Platform is an independent service and is not affiliated with or endorsed by the U.S. Government. Official notices, amendments, attachments, eligibility requirements, funding terms, and deadlines remain under source control.
OIP scores and explanations are informational and do not guarantee eligibility, suitability, compliance, contract award, or financial outcome.
No funding amount is disclosed in the stored source fields.
Small businesses
2 warning(s) require review.
Objective score, derived by OIP · How it works
Publication decision: Publish with warning
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) -- a Grant (Grant) issued by National Institutes of Health.
Objective Government score 65 for grants-gov-359671, computed from source evidence and Government scoring configuration.
potential_value (not_applicable): potential_value is structurally not applicable for this Government category. difficulty (insufficient_evidence): difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. time_required (insufficient_evidence): time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. capital_required (insufficient_evidence): capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate. novelty (insufficient_evidence): novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
12 evidence record(s) support this pipeline result.
Next action: Review the official Grants.gov opportunity and follow the listed application package instructions.
86/100 · Ok
evidence_quality reflects a federal-source baseline plus completeness of deadline, funding value, eligibility, and official-source fields on this specific record.
75/100 · Ok
confidence reflects OIP's confidence in its own interpretation of this record's lifecycle and funding-value status, not confidence that any applicant will qualify.
No numeric value · Not Applicable
potential_value is structurally not applicable for this Government category.
48/100 · Ok
urgency reflects the number of days remaining until the disclosed application deadline.
No numeric value · Insufficient Evidence
difficulty could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
time_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
No numeric value · Insufficient Evidence
capital_required could not be scored: no application-complexity, preparation-burden, or applicant-cost evidence is available for this opportunity beyond generic boilerplate.
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
$.detail.opportunityTitle · Field Mapping · 98/100 confidence
359671 / PA-27-100
$.detail.id · Field Mapping · 99/100 confidence
National Institutes of Health
$.detail.synopsis.agencyName · Field Mapping · 97/100 confidence
Grant
$.detail.synopsis.fundingInstruments · Field Mapping · 96/100 confidence
The Small Business Innovation Research (SBIR) program helps United States small business concerns (SBCs) bring scientific innovations to the marketplace. The SBIR program supports feasibility studies to later research and development (R&D) needed to develop a commercial product.
$.detail.synopsis.synopsisDesc · Field Mapping · 94/100 confidence
2026-05-28T04:00:00.000Z
$.detail.synopsis.postingDate · Field Mapping · 96/100 confidence
2027-04-05T00:00:00.000Z
$.searchHit.closeDate · Field Mapping · 92/100 confidence
Applicant types: Small businesses
$.detail.synopsis.applicantTypes · Field Mapping · 94/100 confidence
Only United States small business concerns (SBCs), as defined by the Small Business Administration (SBA)(sbir.gov/apply) are eligible to submit applications for this opportunity.Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Unfunded international collaborations or unfunded foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
$.detail.synopsis.applicantEligibilityDesc · Field Mapping · 94/100 confidence
value_not_disclosed
$.detail.synopsis · Field Mapping · 84/100 confidence
Official source materials control eligibility, deadlines, amendments, attachments, and funding terms.
Open official source50/100 · Ok
risk reflects the number of material evidence gaps on this record (undisclosed value, missing deadline, unlisted eligibility, or a stale source date), not ordinary competitive uncertainty.
No numeric value · Insufficient Evidence
novelty could not be scored: no current Government source provides a reliable per-record signal for whether an opportunity is genuinely novel versus long-standing.
2026-06-01T16:56:55.000Z
$.detail.synopsis.lastUpdatedDate · Field Mapping · 88/100 confidence
PA-27-100-Revised-Full-Announcement.html
$.detail.synopsisAttachmentFolders[0].synopsisAttachments[0] · Field Mapping · 90/100 confidence